Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII Technical Analysis Summary (NASDAQ)

Analyze DMII on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

DMII●NASDAQ
Financial ServicesFinancial - Conglomerates
$10.14
$0.00(0.00%)
U.S. Market opens in 51h 8m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DMII Technical Analysis Summary (NASDAQ)

Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Bullish (RSI: 68.51)
Trend Strength:Very Strong (ADX: 53.20)
Volatility:Low (ATR: 0.01)
Support/Resistance:$10.10 – $10.14 (Bollinger Bands)

Technical conditions suggest Drugs Made In America Acquisition II Corp. Ordinary Shares on the NASDAQ is awaiting a decisive move. Overall, Drugs Made In America Acquisition II Corp. Ordinary Shares remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 68.51

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 83.33

Bearish
Overbought levels may trigger pullback.

Williams %R: 0.00

Bearish
Overbought levels may trigger correction.

Rate of Change (ROC): 0.30

Neutral
Price change is minimal.

Takeaway:Insufficient data to determine overall momentum trend.

Trend & Volatility

MACD: 0.01

Bullish
Bullish, trend momentum is strengthening.

ADX: 53.20

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 0.01

Low
Low volatility, stable price action.

CCI (14): 139.05

Bearish Risk
Bearish risk, overbought levels suggest caution.

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators
Bollinger Bands
Upper Band
$10.14
Middle Band (SMA 20)
$10.12
Lower Band
$10.10
Current Position
Within Bands

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels
Upper Channel
$10.14
Middle Line (EMA 20)
$10.12
Lower Channel
$10.10
Squeeze Status
No Squeeze

Takeaway:Drugs Made In America Acquisition II Corp. Ordinary Shares trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis
On-Balance Volume-605.34K
Money Flow Index97.25Bearish risk, overbought conditions may trigger pullback.
Relative Vigor Index23.81Bearish, price momentum favors sellers.

Overall Takeaway:DMII shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

MFI above 80 → overbought conditions may limit upside.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Drugs Made In America Acquisition II Corp. Ordinary Shares currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.

(NASDAQ: DMII) Technical Analysis FAQ